{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:25:35Z","timestamp":1786987535270,"version":"build-2736575974"},"reference-count":251,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.critrevonc.2025.104804","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T07:27:32Z","timestamp":1750058852000},"page":"104804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Dual roles of GM-CSF in breast cancer: Immunomodulation and therapeutic implications"],"prefix":"10.1016","volume":"214","author":[{"given":"Yuxuan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingya","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangnan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9268-0527","authenticated-orcid":false,"given":"Yian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.critrevonc.2025.104804_bib1","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.3390\/molecules25204709","article-title":"LPS induces GM-CSF production by breast cancer MDA-MB-231 cells via Long-Chain Acyl-CoA synthetase 1","volume":"25","author":"Al-Rashed","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-022-06562-y","article-title":"The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II-III and metastatic breast cancers","volume":"194","author":"Anderson","year":"2022","journal-title":"Breast Cancer Res Treat."},{"issue":"Pt 2","key":"10.1016\/j.critrevonc.2025.104804_bib3","article-title":"A comprehensive review of immune checkpoint inhibitors for cancer treatment","volume":"143","author":"Arafat Hossain","year":"2024","journal-title":"Int Immunopharmacol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12016-019-08739-8","article-title":"Immunologic adverse effects of biologics for the treatment of atopy","volume":"59","author":"Aranez","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104804_bib5","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/med.21971","article-title":"(Nano)platforms in breast cancer therapy: Drug\/gene delivery, advanced nanocarriers and immunotherapy","volume":"43","author":"Ashrafizadeh","year":"2023","journal-title":"Med Res Rev."},{"issue":"7971","key":"10.1016\/j.critrevonc.2025.104804_bib6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-023-06243-w","article-title":"CAR T therapy beyond cancer: the evolution of a living drug","volume":"619","author":"Baker","year":"2023","journal-title":"Nature"},{"issue":"40","key":"10.1016\/j.critrevonc.2025.104804_bib7","doi-asserted-by":"crossref","first-page":"33814","DOI":"10.1021\/acsami.8b07609","article-title":"Inflammatory role of Cancer-Associated fibroblasts in invasive breast tumors revealed using a fibrous polymer scaffold","volume":"10","author":"Balachander","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.dci.2003.09.010","article-title":"Regulation of myeloid development and function by colony stimulating factors","volume":"28","author":"Barreda","year":"2004","journal-title":"Dev. Comp. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib9","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.immuni.2016.10.026","article-title":"GM-CSF: from growth factor to central mediator of tissue inflammation","volume":"45","author":"Becher","year":"2016","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104804_bib10","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-20-3317","article-title":"Inhibition of jumonji histone demethylases selectively suppresses HER2+ breast leptomeningeal carcinomatosis growth via inhibition of GMCSF expression","volume":"81","author":"Bhan","year":"2021","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104804_bib11","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201963","article-title":"CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation","volume":"219","author":"Boieri","year":"2022","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104804_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3727\/096504009790217399","article-title":"Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms","volume":"18","author":"Boucharaba","year":"2009","journal-title":"Oncol. Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104804_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41389-018-0042-x","article-title":"SNAIL1 action in tumor cells influences macrophage polarization and metastasis in breast cancer through altered GM-CSF secretion","volume":"7","author":"Brenot","year":"2018","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/nar\/gki161","article-title":"GM-CSF promoter chromatin remodelling and gene transcription display distinct signal and transcription factor requirements","volume":"33","author":"Brettingham-Moore","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.critrevonc.2025.104804_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104804_bib16","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1158\/0008-5472.CAN-12-3425","article-title":"Inhibition of SRC corrects GM-CSF hypersensitivity that underlies juvenile myelomonocytic leukemia","volume":"73","author":"Bunda","year":"2013","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104804_bib17","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.immuni.2023.07.018","article-title":"Targeting innate immune pathways for cancer immunotherapy","volume":"56","author":"Cao","year":"2023","journal-title":"Immunity"},{"issue":"10304","key":"10.1016\/j.critrevonc.2025.104804_bib18","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","article-title":"Immune checkpoint inhibitors in melanoma","volume":"398","author":"Carlino","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cncr.24756","article-title":"Results of the first phase 1 clinical trial of the HER-2\/neu peptide (GP2) vaccine in disease-free breast cancer patients: United States military cancer institute clinical trials group study I-04","volume":"116","author":"Carmichael","year":"2010","journal-title":"Cancer"},{"issue":"6401","key":"10.1016\/j.critrevonc.2025.104804_bib20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/360258a0","article-title":"GM-CSF and TNF-alpha cooperate in the generation of dendritic langerhans cells","volume":"360","author":"Caux","year":"1992","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2141.1992.tb08891.x","article-title":"The dissociation of GM-CSF efficacy from toxicity according to route of administration: a pharmacodynamic study","volume":"80","author":"Cebon","year":"1992","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104804_bib22","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s11912-022-01339-4","article-title":"Immune checkpoint inhibitors and novel immunotherapy approaches for breast cancer","volume":"24","author":"Cejuela","year":"2022","journal-title":"Curr. Oncol. Rep."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104804_bib23","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1021\/acs.molpharmaceut.2c00897","article-title":"Design of a tumor binding GMCSF as intratumoral immunotherapy of solid tumors","volume":"20","author":"Chakravarti","year":"2023","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104804_bib24","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1007\/s12010-014-1373-5","article-title":"Overexpression of granulocyte macrophage colony stimulating factor in breast cancer cells leads towards drug sensitization","volume":"175","author":"Chaubey","year":"2015","journal-title":"Appl. Biochem Biotechnol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104804_bib25","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1158\/2326-6066.CIR-14-0058","article-title":"A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer","volume":"2","author":"Chen","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.critrevonc.2025.104804_bib26","article-title":"Role of GM-CSF in lung balance and disease","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2025.104804_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108679","article-title":"Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer","volume":"225","author":"Chick","year":"2021","journal-title":"Clin. Immunol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104804_bib28","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1158\/1078-0432.CCR-19-2741","article-title":"Results of a randomized phase IIb trial of Nelipepimut-S + trastuzumab versus trastuzumab to prevent recurrences in patients with High-Risk HER2 Low-Expressing breast cancer","volume":"26","author":"Clifton","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104804_bib29","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1245\/s10434-017-5844-0","article-title":"Results of a phase ib trial of combination immunotherapy with a CD8+ T cell eliciting vaccine and trastuzumab in breast cancer patients","volume":"24","author":"Clifton","year":"2017","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/jso.21723","article-title":"The GP2 peptide: a HER2\/neu-based breast cancer vaccine","volume":"105","author":"Clive","year":"2012","journal-title":"J. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104804_bib31","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/eji.200425110","article-title":"Macrophage colony-stimulating factor-, granulocyte-macrophage colony-stimulating factor-, or IL-3-dependent survival of macrophages, but not proliferation, requires the expression of p21(Waf1) through the phosphatidylinositol 3-kinase\/Akt pathway","volume":"34","author":"Comalada","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104804_bib32","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/1878-0261.13450","article-title":"Dual VEGFA\/BRAF targeting boosts PD-1 blockade in melanoma through GM-CSF-mediated infiltration of M1 macrophages","volume":"17","author":"Comunanza","year":"2023","journal-title":"Mol. Oncol."},{"issue":"10265","key":"10.1016\/j.critrevonc.2025.104804_bib33","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104804_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus chemotherapy in advanced Triple-Negative breast cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104804_bib35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/13543784.2022.2054326","article-title":"CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress","volume":"31","author":"Corti","year":"2022","journal-title":"Expert Opin. Invest. Drugs."},{"key":"10.1016\/j.critrevonc.2025.104804_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semcancer.2021.07.011","article-title":"Neutrophil extracellular traps in cancer","volume":"79","author":"Cristinziano","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104804_bib37","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.4049\/jimmunol.1001965","article-title":"GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation","volume":"187","author":"Curran","year":"2011","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104804_bib38","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors","volume":"107","author":"Curran","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104804_bib39","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/mt.2008.1","article-title":"Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer","volume":"16","author":"Dai","year":"2008","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104804_bib40","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0898-6568(98)00023-0","article-title":"Regulation of proliferation, differentiation and survival by the IL-3\/IL-5\/GM-CSF receptor family","volume":"10","author":"de Groot","year":"1998","journal-title":"Cell Signal"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104804_bib41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamaoncol.2022.5143","article-title":"Safety and outcomes of a plasmid DNA vaccine encoding the ERBB2 intracellular domain in patients with Advanced-Stage ERBB2-Positive breast cancer: a phase 1 nonrandomized clinical trial","volume":"9","author":"Disis","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2025.104804_bib43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1034\/j.1600-065X.2002.18813.x","article-title":"GM-CSF-based cancer vaccines","volume":"188","author":"Dranoff","year":"2002","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib44","first-page":"80","article-title":"Recombinant interferon alfa in BCR\/ABL-negative chronic myeloproliferative neoplasms","volume":"22","author":"El Bitar","year":"2024","journal-title":"Clin. Adv. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104804_bib45","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.molonc.2014.12.010","article-title":"Modulation of the tumor microenvironment and inhibition of EGF\/EGFR pathway: novel anti-tumor mechanisms of cannabidiol in breast cancer","volume":"9","author":"Elbaz","year":"2015","journal-title":"Mol. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104804_bib46","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/cancers14041042","article-title":"Tumor Cell-Autonomous Pro-Metastatic activities of PD-L1 in human breast cancer are mediated by PD-L1-S283 and chemokine axes","volume":"14","author":"Erlichman","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib47","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3892\/ijo.2017.4128","article-title":"Evidence of lateral transmission of aggressive features between different types of breast cancer cells","volume":"51","author":"Espinoza-S\u00e1nchez","year":"2017","journal-title":"Int J. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib48","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1158\/0008-5472.CAN-08-1405","article-title":"Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages","volume":"69","author":"Eubank","year":"2009","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib49","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2002-06-1890","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia","volume":"102","author":"Faderl","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib50","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1158\/0008-5472.CAN-08-3529","article-title":"Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF","volume":"69","author":"Fong","year":"2009","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10522-006-9067-1","article-title":"GM-CSF activates the Jak\/STAT pathway to rescue polymorphonuclear neutrophils from spontaneous apoptosis in young but not elderly individuals","volume":"8","author":"Fortin","year":"2007","journal-title":"Biogerontology"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104804_bib52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108958","article-title":"Protein kinase d drives the secretion of invasion mediators in triple-negative breast cancer cell lines","volume":"27","author":"Gali","year":"2024","journal-title":"iScience"},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104804_bib54","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1158\/0008-5472.CAN-16-2774","article-title":"Trastuzumab increases HER2 uptake and Cross-Presentation by dendritic cells","volume":"77","author":"Gall","year":"2017","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104804_bib55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12964-023-01043-1","article-title":"c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment","volume":"21","author":"Gao","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib57","doi-asserted-by":"crossref","first-page":"016","DOI":"10.1186\/s13058-016-0703-7","article-title":"Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment","volume":"18","author":"Garc\u00eda-Mendoza","year":"2016","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104804_bib58","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood.V77.6.1131.1131","article-title":"Molecular physiology of granulocyte-macrophage colony-stimulating factor","volume":"77","author":"Gasson","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2025.104804_bib59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semcancer.2020.06.016","article-title":"Immune checkpoint inhibitors: key trials and an emerging role in breast cancer","volume":"79","author":"Gaynor","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"14","key":"10.1016\/j.critrevonc.2025.104804_bib60","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1158\/0008-5472.CAN-14-2386","article-title":"Breast cancer Cell-Derived GM-CSF licenses regulatory Th2 induction by plasmacytoid predendritic cells in aggressive disease subtypes","volume":"75","author":"Ghirelli","year":"2015","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104804_bib61","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nri2356","article-title":"Colony-stimulating factors in inflammation and autoimmunity","volume":"8","author":"Hamilton","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib62","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190945","article-title":"GM-CSF in inflammation","volume":"217","author":"Hamilton","year":"2020","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104804_bib63","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.immuni.2015.05.018","article-title":"GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c(+)MHCII(+) macrophages and dendritic cells","volume":"42","author":"Helft","year":"2015","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ijc.23474","article-title":"Combination of fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine lewis lung carcinoma","volume":"123","author":"Ho","year":"2008","journal-title":"Int J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib65","first-page":"913","article-title":"In-vivo stimulation of cell-proliferation of 2 human tumor xenograft lines by granulocyte-macrophage colony-stimulating factor (gm-csf)","volume":"1","author":"Hofmockel","year":"1994","journal-title":"Oncol. Rep."},{"issue":"20","key":"10.1016\/j.critrevonc.2025.104804_bib66","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2007.15.7842","article-title":"Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2\/neu peptide (AE37) vaccine","volume":"26","author":"Holmes","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib67","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1634\/theoncologist.4-2-106","article-title":"Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer","volume":"4","author":"Honkoop","year":"1999","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2025.104804_bib68","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mehy.2016.07.009","article-title":"Melanoma exosome induction of endothelial cell GM-CSF in pre-metastatic lymph nodes May result in different M1 and M2 macrophage mediated angiogenic processes","volume":"94","author":"Hood","year":"2016","journal-title":"Med. Hypotheses"},{"issue":"46","key":"10.1016\/j.critrevonc.2025.104804_bib69","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.1038\/sj.onc.1206856","article-title":"An increase in the expression and total activity of endogenous p60(c-Src) in several factor-independent mutants of a human GM-CSF-dependent leukemia cell line (TF-1)","volume":"22","author":"Horn","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2025.104804_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104011","article-title":"IL-32 and its paradoxical role in neoplasia","volume":"186","author":"Hough","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13073-023-01164-9","article-title":"Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing","volume":"15","author":"Hu","year":"2023","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib72","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-022-01515-x","article-title":"Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer","volume":"21","author":"Huang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104804_bib73","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4161\/auto.28772","article-title":"Autophagy promotes radiation-induced senescence but inhibits bystander effects in human breast cancer cells","volume":"10","author":"Huang","year":"2014","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib74","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00262-006-0188-9","article-title":"Analysis of na\u00efve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2\/neu peptide (E75) and GM-CSF vaccine","volume":"56","author":"Hueman","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10549-005-9108-5","article-title":"Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2\/neu peptide (E75) and GM-CSF vaccine","volume":"98","author":"Hueman","year":"2006","journal-title":"Breast Cancer Res Treat."},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104804_bib76","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1093\/nar\/27.18.3660","article-title":"The 5\u2032-untranslated region of GM-CSF mRNA suppresses translational repression mediated by the 3\u2032 adenosine-uridine-rich element and the poly(A) tail","volume":"27","author":"Jarzembowski","year":"1999","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib77","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13058-021-01481-0","article-title":"STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment","volume":"23","author":"Jesser","year":"2021","journal-title":"Breast Cancer Res."},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104804_bib78","article-title":"Modular hydrogel vaccine for programmable and coordinate elicitation of cancer immunotherapy","volume":"10","author":"Ji","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104804_bib79","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.4049\/jimmunol.175.3.1456","article-title":"Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response","volume":"175","author":"Ji","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2025.104804_bib80","article-title":"Administration of granulocyte-macrophage colony-stimulating factor enhanced chimeric antigen receptor T-cell expansion and cellular immunity recovery without inducing cytokine release syndrome","volume":"9","author":"Jiang","year":"2022","journal-title":"Front Med. (Lausanne)"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib81","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104804_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009541","article-title":"Engineered GM-CSF polarizes protumorigenic tumor-associated macrophages to an antitumorigenic phenotype and potently synergizes with IL-12 immunotherapy","volume":"12","author":"Kang","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib83","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104804_bib84","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/sj.onc.1210778","article-title":"CBAP interacts with the un-liganded common beta-subunit of the GM-CSF\/IL-3\/IL-5 receptor and induces apoptosis via mitochondrial dysfunction","volume":"27","author":"Kao","year":"2008","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib85","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s10753-018-0825-4","article-title":"Inflammation-Induced Epithelial-to-Mesenchymal transition and GM-CSF treatment stimulate mesenteric mesothelial cells to transdifferentiate into macrophages","volume":"41","author":"Katz","year":"2018","journal-title":"Inflammation"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104804_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023025","article-title":"GM-CSF signalling boosts dramatically IL-1 production","volume":"6","author":"Khameneh","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104804_bib87","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cell.2009.11.025","article-title":"Tumor self-seeding by circulating cancer cells","volume":"139","author":"Kim","year":"2009","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104804_bib88","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41573-024-00896-6","article-title":"The present and future of bispecific antibodies for cancer therapy","volume":"23","author":"Klein","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib89","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF01737684","article-title":"Order of human hematopoietic growth factor and receptor genes on the long arm of chromosome 5, as determined by fluorescence in situ hybridization","volume":"66","author":"Kluck","year":"1993","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib90","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1158\/1078-0432.CCR-19-2123","article-title":"Rapid generation of sustainable HER2-specific T-cell immunity in patients with HER2 breast cancer using a degenerate HLA class II epitope vaccine","volume":"26","author":"Knutson","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104804_bib91","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.2147\/IJN.S373282","article-title":"Multifunctional Nanoparticles-Mediated PTT\/PDT synergistic immune activation and antitumor activity combined with Anti-PD-L1 immunotherapy for breast cancer treatment","volume":"17","author":"Kong","year":"2022","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.critrevonc.2025.104804_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.952066","article-title":"PD-1 inhibitor combined with radiotherapy and GM-CSF (PRaG) in patients with metastatic solid tumors: an Open-Label phase II study","volume":"13","author":"Kong","year":"2022","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104804_bib93","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/stem.1793","article-title":"Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells","volume":"32","author":"Krishnamurthy","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.critrevonc.2025.104804_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.901277","article-title":"GM-CSF: a Double-Edged sword in cancer immunotherapy","volume":"13","author":"Kumar","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2025.104804_bib95","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3389\/fimmu.2018.00776","article-title":"SV-BR-1-GM, a clinically effective GM-CSF-Secreting breast cancer cell line, expresses an immune signature and directly activates CD4+ T lymphocytes","volume":"9","author":"Lacher","year":"2018","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104804_bib96","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1158\/2159-8290.CD-20-0896","article-title":"A chimeric GM-CSF\/IL18 receptor to sustain CAR T-cell function","volume":"11","author":"Lange","year":"2021","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104804_bib97","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.mucimm.2023.03.006","article-title":"iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis","volume":"16","author":"Lattanzi","year":"2023","journal-title":"Mucosal Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104804_bib98","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","article-title":"Cancer-associated fibroblasts in the single-cell era","volume":"3","author":"Lavie","year":"2022","journal-title":"Nat. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib99","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2478\/ams-2013-0023","article-title":"Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients","volume":"58","author":"\u0141awicki","year":"2013","journal-title":"Adv. Med Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104804_bib100","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/CJI.0b013e31829fb7a2","article-title":"Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer","volume":"36","author":"Le","year":"2013","journal-title":"J. Immunother."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib101","doi-asserted-by":"crossref","first-page":"9610","DOI":"10.1038\/s41598-017-09040-4","article-title":"Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104804_bib102","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/jcp.22507","article-title":"Requirement for PLC\u03b32 in IL-3 and GM-CSF-stimulated MEK\/ERK phosphorylation in murine and human hematopoietic stem\/progenitor cells","volume":"226","author":"Leon","year":"2011","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib103","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1038\/s41467-019-11304-8","article-title":"Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib104","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.critrevonc.2025.104804_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216190","article-title":"Application prospect of circular RNA-based neoantigen vaccine in tumor immunotherapy","volume":"563","author":"Li","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib106","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","article-title":"Aerobic glycolysis controls Myeloid-Derived suppressor cells and tumor immunity via a specific CEBPB isoform in Triple-Negative breast cancer","volume":"28","author":"Li","year":"2018","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib107","first-page":"1352","article-title":"Nicotinamide n -methyltransferase promotes M2 macrophage polarization by IL6 and MDSC conversion by GM-CSF in gallbladder carcinoma","volume":"78","author":"Li","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib108","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00018-024-05290-4","article-title":"Disrupting Smad3 potentiates immunostimulatory function of NK cells against lung carcinoma by promoting GM-CSF production","volume":"81","author":"Lian","year":"2024","journal-title":"Cell Mol. Life Sci."},{"issue":"43","key":"10.1016\/j.critrevonc.2025.104804_bib109","doi-asserted-by":"crossref","first-page":"11060","DOI":"10.1073\/pnas.1811717115","article-title":"Metastatic growth instructed by neutrophil-derived transferrin","volume":"115","author":"Liang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104804_bib110","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.3390\/cancers13225703","article-title":"Silencing CTNND1 mediates Triple-Negative breast cancer bone metastasis via upregulating CXCR4\/CXCL12 axis and neutrophils infiltration in bone","volume":"13","author":"Lin","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104804_bib111","doi-asserted-by":"crossref","first-page":"5919","DOI":"10.1158\/0008-5472.CAN-21-1337","article-title":"ALDH1A1 activity in Tumor-Initiating cells remodels Myeloid-Derived suppressor cells to promote breast cancer progression","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104804_bib112","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1007\/s00432-022-04509-w","article-title":"IL-2\/GM-CSF enhances CXCR3 expression in CAR-T cells via the PI3K\/AKT and ERK1\/2 pathways","volume":"149","author":"Liu","year":"2023","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104804_bib113","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.3390\/cancers15092626","article-title":"c-Met mediated cytokine network promotes brain metastasis of breast cancer by remodeling neutrophil activities","volume":"15","author":"Liu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2025.104804_bib114","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3389\/fimmu.2019.01265","article-title":"Roles of GM-CSF in the pathogenesis of autoimmune diseases: an update","volume":"10","author":"Lotfi","year":"2019","journal-title":"Front Immunol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104804_bib115","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib116","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0394632017711055","article-title":"MDSCs are involved in the protumorigenic potentials of GM-CSF in colitis-associated cancer","volume":"30","author":"Ma","year":"2017","journal-title":"Int J. Immunopathol. Pharm."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib117","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33397-9","article-title":"The interplay between adipose-derived stem cells and bladder cancer cells","volume":"8","author":"Maj","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104804_bib118","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/1878-0261.13818","article-title":"Cytokine-centered strategies to boost cancer immunotherapy","volume":"19","author":"Manzano","year":"2025","journal-title":"Mol. Oncol."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104804_bib119","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/blood-2011-04-350694","article-title":"Negative effects of GM-CSF signaling in a murine model of t(8;21)-induced leukemia","volume":"119","author":"Matsuura","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/13543784.2021.1849140","article-title":"AE37: a HER2-targeted vaccine for the prevention of breast cancer recurrence","volume":"30","author":"McCarthy","year":"2021","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.critrevonc.2025.104804_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.643771","article-title":"Macrophage biology and mechanisms of immune suppression in breast cancer","volume":"12","author":"Mehta","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2025.104804_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115808","article-title":"Scutellarin suppresses the metastasis of triple-negative breast cancer via targeting TNF\u03b1\/TNFR2-RUNX1-triggered G-CSF expression in endothelial cells","volume":"217","author":"Mei","year":"2023","journal-title":"Biochem Pharm."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib123","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3048","article-title":"Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2\/CBF\u03b2-dependent expression of the wnt antagonist, sclerostin","volume":"13","author":"Mendoza-Villanueva","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104804_bib124","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1158\/2326-6066.CIR-13-0151","article-title":"The colony-stimulating factors and cancer","volume":"1","author":"Metcalf","year":"2013","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41423-020-0412-0","article-title":"Neutrophil chemoattractant receptors in health and disease: double-edged swords","volume":"17","author":"Metzemaekers","year":"2020","journal-title":"Cell Mol. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104804_bib126","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/BJ20091745","article-title":"The Ig-like domain of human GM-CSF receptor alpha plays a critical role in cytokine binding and receptor activation","volume":"426","author":"Mirza","year":"2010","journal-title":"Biochem J."},{"issue":"40","key":"10.1016\/j.critrevonc.2025.104804_bib127","doi-asserted-by":"crossref","first-page":"66192","DOI":"10.18632\/oncotarget.11751","article-title":"Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence","volume":"7","author":"Mittendorf","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104804_bib128","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/annonc\/mdw150","article-title":"Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence","volume":"27","author":"Mittendorf","year":"2016","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104804_bib129","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/annonc\/mdu211","article-title":"Final report of the phase I\/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients","volume":"25","author":"Mittendorf","year":"2014","journal-title":"Ann. Oncol."},{"issue":"14","key":"10.1016\/j.critrevonc.2025.104804_bib130","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1158\/1078-0432.CCR-18-2867","article-title":"Efficacy and safety analysis of Nelipepimut-S vaccine to prevent breast cancer recurrence: a randomized, multicenter, phase III clinical trial","volume":"25","author":"Mittendorf","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104804_bib131","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/cncr.21849","article-title":"Evaluation of the HER2\/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial","volume":"106","author":"Mittendorf","year":"2006","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104804_bib132","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1200\/JCO.20.00203","article-title":"Irinotecan, temozolomide, and dinutuximab with GM-CSF in children with refractory or relapsed neuroblastoma: a report from the children's oncology group","volume":"38","author":"Mody","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104804_bib133","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1073\/pnas.84.13.4428","article-title":"Increased biological activity of deglycosylated recombinant human granulocyte\/macrophage colony-stimulating factor produced by yeast or animal cells","volume":"84","author":"Moonen","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib134","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41420-022-01240-w","article-title":"Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF\/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF","volume":"8","author":"Mukherjee","year":"2022","journal-title":"Cell Death Discov."},{"issue":"16","key":"10.1016\/j.critrevonc.2025.104804_bib135","doi-asserted-by":"crossref","first-page":"8377","DOI":"10.3390\/ijms22168377","article-title":"Dendritic cells pulsed with Cytokine-Adjuvanted tumor membrane vesicles inhibit tumor growth in HER2-Positive and triple negative breast cancer models","volume":"22","author":"Munoz","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104804_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1399754","article-title":"Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches","volume":"15","author":"Naji","year":"2024","journal-title":"Front Immunol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104804_bib137","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","article-title":"Deciphering breast cancer: from biology to the clinic","volume":"186","author":"Nolan","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2025.104804_bib138","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1479-5876-8-53","article-title":"Vaccination with a plasmid DNA encoding HER-2\/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial","volume":"8","author":"Norell","year":"2010","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104804_bib139","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/oxfordjournals.annonc.a058975","article-title":"A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients","volume":"5","author":"O'Shaughnessy","year":"1994","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104804_bib140","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood.V87.6.2205.bloodjournal8762205","volume":"87","author":"O\u2019Shaughnessy","year":"1996","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104804_bib141","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1158\/1940-6207.CAPR-22-0388","article-title":"Phase II trial of Nelipepimut-S peptide vaccine in women with ductal carcinoma in situ","volume":"16","author":"O\u2019Shea","year":"2023","journal-title":"Cancer Prev. Res. (Phila)"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104804_bib142","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF02966444","article-title":"Adenoviral GM-CSF gene transduction into breast cancer cells induced Long-Lasting antitumor immunity in mice","volume":"6","author":"Ogawa","year":"1999","journal-title":"Breast Cancer"},{"issue":"6\u20138","key":"10.1016\/j.critrevonc.2025.104804_bib143","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.imbio.2006.06.010","article-title":"Preoperative granulocyte\/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients","volume":"211","author":"Oosterling","year":"2006","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib144","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm1519","article-title":"NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF","volume":"13","author":"Park","year":"2007","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jamcollsurg.2009.10.022","article-title":"Clinical and immunologic responses of HLA-A3+ breast cancer patients vaccinated with the HER2\/neu-derived peptide vaccine, E75, in a phase I\/II clinical trial","volume":"210","author":"Patil","year":"2010","journal-title":"J. Am. Coll. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib146","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.bjc.6690009","article-title":"Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells","volume":"79","author":"Pei","year":"1999","journal-title":"Br. J. Cancer"},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104804_bib147","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","article-title":"Spatially organized multicellular immune hubs in human colorectal cancer","volume":"184","author":"Pelka","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2025.104804_bib148","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cytogfr.2021.01.001","article-title":"Granulocyte macrophage colony-stimulating factor has come of age: from a vaccine adjuvant to antiviral immunotherapy","volume":"59","author":"Petrina","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.critrevonc.2025.104804_bib149","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fimmu.2019.00138","article-title":"Human mast cells from adipose tissue target and induce apoptosis of breast cancer cells","volume":"10","author":"Plotkin","year":"2019","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib150","first-page":"6","volume":"6","author":"Poh","year":"2016","journal-title":"First Oncolytic Viral Ther. Melanoma Cancer Discov."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104804_bib151","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104804_bib152","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ccr.2012.04.024","article-title":"Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia","volume":"21","author":"Pylayeva-Gupta","year":"2012","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104804_bib153","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1159\/000358652","article-title":"GM-CSF induces cyclin D1 expression and proliferation of endothelial progenitor cells via PI3K and MAPK signaling","volume":"33","author":"Qiu","year":"2014","journal-title":"Cell Physiol. Biochem."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104804_bib154","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220011","article-title":"Neutrophil phenotypes and functions in cancer: a consensus statement","volume":"219","author":"Quail","year":"2022","journal-title":"J. Exp. Med"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104804_bib155","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/ncb3578","article-title":"Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF","volume":"19","author":"Quail","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104804_bib156","doi-asserted-by":"crossref","first-page":"8896","DOI":"10.1158\/0008-5472.CAN-05-1734","article-title":"Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression","volume":"65","author":"Queen","year":"2005","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib157","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1038\/s41467-024-46835-2","article-title":"Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma","volume":"15","author":"Ramirez","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.104804_bib158","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.omto.2022.01.009","article-title":"Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer","volume":"24","author":"Rangsitratkul","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104804_bib159","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.21.01497","article-title":"First-Line immunotherapy for Non-Small-Cell lung cancer","volume":"40","author":"Reck","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104804_bib160","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1158\/0008-5472.CAN-17-0914","article-title":"Adipose progenitor cell secretion of GM-CSF and MMP9 promotes a stromal and immunological microenvironment that supports breast cancer progression","volume":"77","author":"Reggiani","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104804_bib161","article-title":"Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients","volume":"10 (10)","author":"Renner","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104804_bib162","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T cell response","volume":"12","author":"Restifo","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104804_bib163","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","article-title":"IL-2: the first effective immunotherapy for human cancer","volume":"192","author":"Rosenberg","year":"2014","journal-title":"J. Immunol."},{"issue":"17","key":"10.1016\/j.critrevonc.2025.104804_bib164","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.1073\/pnas.83.17.6613","article-title":"Interferon gamma and granulocyte\/macrophage colony-stimulating factor inhibit growth and induce antigens characteristic of myeloid differentiation in small-cell lung cancer cell lines","volume":"83","author":"Ruff","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2025.104804_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1212476","article-title":"Cancer immunotherapies: advances and bottlenecks","volume":"14","author":"Rui","year":"2023","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104804_bib166","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/cgt.2016.80","article-title":"Therapeutic vaccination based on side population cells transduced by the granulocyte-macrophage colony-stimulating factor gene elicits potent antitumor immunity","volume":"24","author":"Sakamoto","year":"2017","journal-title":"Cancer Gene Ther."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib167","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/0008-5472.CAN-19-2374","article-title":"The immunosuppressive microenvironment in BRCA1-IRIS-Overexpressing TNBC tumors is induced by bidirectional interaction with Tumor-Associated macrophages","volume":"80","author":"Sami","year":"2020","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib168","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.celrep.2016.08.075","article-title":"Mesenchymal transition of High-Grade breast carcinomas depends on extracellular matrix control of myeloid suppressor cell activity","volume":"17","author":"Sangaletti","year":"2016","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib169","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00417-012-1932-9","article-title":"GM-CSF protects rat photoreceptors from death by activating the SRC-dependent signalling and elevating anti-apoptotic factors and neurotrophins","volume":"250","author":"Schallenberg","year":"2012","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib170","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2217\/imt.14.22","article-title":"The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax\u2122) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response","volume":"6","author":"Schneble","year":"2014","journal-title":"Immunotherapy"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib171","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijbiomac.2009.04.005","article-title":"Molecular cloning, expression in escherichia coli and production of bioactive homogeneous recombinant human granulocyte and macrophage colony stimulating factor","volume":"45","author":"Schwanke","year":"2009","journal-title":"Int J. Biol. Macromol."},{"issue":"3\u20134","key":"10.1016\/j.critrevonc.2025.104804_bib172","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1615\/CritRevImmunol.v17.i3-4.30","article-title":"Signals for activation of the GM-CSF promoter and enhancer in T cells","volume":"17","author":"Shannon","year":"1997","journal-title":"Crit. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib173","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jlb.57.5.767","article-title":"GM-CSF and IL-2 share common control mechanisms in response to costimulatory signals in T cells","volume":"57","author":"Shannon","year":"1995","journal-title":"J. Leukoc. Biol."},{"issue":"553","key":"10.1016\/j.critrevonc.2025.104804_bib174","doi-asserted-by":"crossref","first-page":"eaat5916","DOI":"10.1126\/scisignal.aat5916","article-title":"The src family kinase fgr is a transforming oncoprotein that functions independently of SH3-SH2 domain regulation","volume":"11","author":"Shen","year":"2018","journal-title":"Sci. Signal"},{"issue":"17","key":"10.1016\/j.critrevonc.2025.104804_bib175","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.3390\/ijms21176357","article-title":"Arctigenin attenuates breast cancer progression through decreasing GM-CSF\/TSLP\/STAT3\/\u03b2-Catenin signaling","volume":"21","author":"Shi","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104804_bib176","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/ijc.31219","article-title":"PD-1 blockade enhances the antitumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine","volume":"142","author":"Shi","year":"2018","journal-title":"Int J. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104804_bib177","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201701469","article-title":"Injectable, tough alginate cryogels as cancer vaccines","volume":"7","author":"Shih","year":"2018","journal-title":"Adv. Health Mater."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104804_bib178","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3390\/vaccines9091037","article-title":"Murine dendritic cells grown in Serum-Free culture show potent therapeutic activity when loaded with novel th epitopes in an orthotopic model of HER2pos breast cancer","volume":"9","author":"Showalter","year":"2021","journal-title":"Vaccin. (Basel)"},{"key":"10.1016\/j.critrevonc.2025.104804_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2017.10.012","article-title":"Colony stimulating factors (CSFs): complex roles in atherosclerosis","volume":"122","author":"Singhal","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.critrevonc.2025.104804_bib180","author":"Patel","year":"2021","journal-title":"Can. Res."},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104804_bib181","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1073\/pnas.95.22.13141","article-title":"Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma","volume":"95","author":"Soiffer","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib182","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00262-006-0213-z","article-title":"Ii-Key\/HER-2\/neu(776-790) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2\/neu+ tumors","volume":"56","author":"Sotiriadou","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"issue":"3\u20134","key":"10.1016\/j.critrevonc.2025.104804_bib183","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000430499","article-title":"Role of the tumor microenvironment in breast cancer","volume":"82","author":"Soysal","year":"2015","journal-title":"Pathobiology"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib184","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/bjc.1995.284","article-title":"The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinoma","volume":"72","author":"Steger","year":"1995","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib185","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1007\/BF01705031","article-title":"The side-effect profile of GM-CSF","volume":"20","author":"Stern","year":"1992","journal-title":"Infection"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104804_bib186","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1182\/blood-2018-10-881722","article-title":"GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts","volume":"133","author":"Sterner","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104804_bib187","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1245\/s10434-007-9538-x","article-title":"Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2\/neu vaccine-based immunotherapy for breast cancer: a pilot study","volume":"14","author":"Stojadinovic","year":"2007","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib188","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccr.2014.03.021","article-title":"A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis","volume":"25","author":"Su","year":"2014","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104804_bib189","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.953418","article-title":"Breaking the vicious cycle between breast cancer cells and tumor-associated macrophages","volume":"3","author":"Su","year":"2014","journal-title":"Oncoimmunology"},{"issue":"20","key":"10.1016\/j.critrevonc.2025.104804_bib190","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145296","article-title":"Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment","volume":"131","author":"Su","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2025.104804_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104751","article-title":"Revolutionizing immunotherapy: the next frontier in CAR T-cell engineering","volume":"211","author":"Suchiita","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104804_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111158","article-title":"Blocking DCIR mitigates colitis and prevents colorectal tumors by enhancing the GM-CSF-STAT5 pathway","volume":"40","author":"Sun","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.critrevonc.2025.104804_bib193","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.616367","article-title":"Glutamine deprivation promotes the generation and mobilization of MDSCs by enhancing expression of G-CSF and GM-CSF","volume":"11","author":"Sun","year":"2021","journal-title":"Front Immunol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104804_bib194","doi-asserted-by":"crossref","first-page":"12975","DOI":"10.1002\/cam4.5969","article-title":"Maintenance regimen of GM-CSF with rituximab and lenalidomide improves survival in high-risk B-cell lymphoma by modulating natural killer cells","volume":"12","author":"Sun","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2025.104804_bib195","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.intimp.2017.02.028","article-title":"Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo","volume":"46","author":"Sunay","year":"2017","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2025.104804_bib196","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.868813","article-title":"Mapping breast cancer microenvironment through Single-Cell omics","volume":"13","author":"Tan","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2025.104804_bib197","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.884648","article-title":"Cytokine-Induced Memory-Like NK cells: from the basics to clinical applications","volume":"13","author":"Terr\u00e9n","year":"2022","journal-title":"Front Immunol."},{"issue":"17","key":"10.1016\/j.critrevonc.2025.104804_bib198","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2217\/fon-2020-0137","article-title":"Gmcsf and Ifn\u03b1 gene therapy improves the response to BCG immunotherapy in a murine model of bladder cancer","volume":"16","author":"Tham","year":"2020","journal-title":"Future Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104804_bib199","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3390\/biom9100555","article-title":"ACSL1 regulates TNF\u03b1-Induced GM-CSF production by breast cancer MDA-MB-231 cells","volume":"9","author":"Thomas","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.critrevonc.2025.104804_bib200","article-title":"A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity","volume":"1","author":"Tian","year":"2016","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib201","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12885-019-5509-4","article-title":"Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion","volume":"19","author":"Tiwari","year":"2019","journal-title":"BMC Cancer"},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104804_bib202","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1158\/0008-5472.CAN-19-0880","article-title":"AMPK Alpha-1 intrinsically regulates the function and differentiation of tumor Myeloid-Derived suppressor cells","volume":"79","author":"Trillo-Tinoco","year":"2019","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104804_bib203","first-page":"7925","article-title":"Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte\/monocyte-colony stimulating factor","volume":"61","author":"Tso","year":"2001","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib204","first-page":"365","article-title":"Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1\/ERK and AKT\/PKB pathways","volume":"18","author":"Uemura","year":"2006","journal-title":"Int J. Mol. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib205","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/blood.V72.1.134.134","article-title":"Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor","volume":"72","author":"Vadhan-Raj","year":"1988","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib206","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1096\/fj.01-0633fje","article-title":"In vivo activation of JAK2\/STAT-3 pathway during angiogenesis induced by GM-CSF","volume":"16","author":"Valdembri","year":"2002","journal-title":"Faseb J."},{"issue":"10396","key":"10.1016\/j.critrevonc.2025.104804_bib207","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(23)00521-4","article-title":"T-cell-engaging bispecific antibodies in cancer","volume":"402","author":"van de Donk","year":"2023","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104804_bib208","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1182\/blood-2011-11-370130","article-title":"Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy","volume":"119","author":"van de Laar","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib209","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0300-483X(95)03124-X","article-title":"Immune-mediated side-effects of cytokines in humans","volume":"105","author":"Vial","year":"1995","journal-title":"Toxicology"},{"key":"10.1016\/j.critrevonc.2025.104804_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110729","article-title":"Eosinophils induces glioblastoma cell suppression and apoptosis - roles of GM-CSF and cysteinyl-leukotrienes","volume":"123","author":"Vieira","year":"2023","journal-title":"Int Immunopharmacol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib211","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.celrep.2014.06.011","article-title":"Recruitment of circulating breast cancer cells is stimulated by radiotherapy","volume":"8","author":"Vilalta","year":"2014","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104804_bib212","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jamaoncol.2024.3456","article-title":"Neoadjuvant immune checkpoint inhibitors plus chemotherapy in early breast cancer: a systematic review and Meta-Analysis","volume":"10","author":"Villacampa","year":"2024","journal-title":"JAMA Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104804_bib213","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1158\/2159-8290.CD-15-0947","article-title":"GM-CSF mediates Mesenchymal-Epithelial Cross-talk in pancreatic cancer","volume":"6","author":"Waghray","year":"2016","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104804_bib214","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1172\/JCI68189","article-title":"Myeloid-derived suppressor cell development is regulated by a STAT\/IRF-8 axis","volume":"123","author":"Waight","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104804_bib215","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0022-2836(92)90470-5","article-title":"Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor","volume":"224","author":"Walter","year":"1992","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib216","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1038\/s41467-020-19540-z","article-title":"Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.104804_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216758","article-title":"Unleashing the power of immune checkpoints: Post-translational modification of novel molecules and clinical applications","volume":"588","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2025.104804_bib218","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fimmu.2019.00172","article-title":"MDSCs: key criminals of tumor Pre-metastatic niche formation","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104804_bib219","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/2326-6066.CIR-16-0042","article-title":"Systemic GM-CSF recruits effector T cells into the tumor microenvironment in localized prostate cancer","volume":"4","author":"Wei","year":"2016","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib220","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2379864","article-title":"Results of a phase I\/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer","volume":"20","author":"Wiseman","year":"2024","journal-title":"Hum. Vaccin Immunother."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib221","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2174\/1574892817666220518123331","article-title":"Regression of breast cancer metastases following treatment with irradiated SV-BR-1-GM, a GM-CSF overexpressing breast cancer cell line: intellectual property and immune markers of response","volume":"18","author":"Wiseman","year":"2022","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104804_bib222","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved Atlas of human breast cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104804_bib223","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","article-title":"Neutrophil profiling illuminates anti-tumor antigen-presenting potency","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib224","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy","volume":"21","author":"Wu","year":"2022","journal-title":"Mol. Cancer"},{"issue":"7446","key":"10.1016\/j.critrevonc.2025.104804_bib225","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib226","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1063772","article-title":"Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells","volume":"5","author":"Xiao","year":"2016","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104804_bib227","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","article-title":"Cathepsin c promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation","volume":"39","author":"Xiao","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2025.104804_bib228","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.canlet.2020.07.044","article-title":"CAR T-cell therapy for triple-negative breast cancer: where we are","volume":"491","author":"Xie","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib229","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","article-title":"Neutrophils in cancer carcinogenesis and metastasis","volume":"14","author":"Xiong","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104804_bib230","first-page":"5334","article-title":"Antiproliferative and differentiative effect of granulocyte-macrophage colony-stimulating factor on a variant human small cell lung cancer cell line","volume":"49","author":"Yamashita","year":"1989","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib231","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40164-023-00373-7","article-title":"Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment","volume":"12","author":"Yan","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104804_bib232","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.7150\/ijbs.70120","article-title":"CAR-T cell therapy for breast cancer: from basic research to clinical application","volume":"18","author":"Yang","year":"2022","journal-title":"Int J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104804_bib233","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1021\/acsnano.8b07371","article-title":"Surgical Tumor-Derived personalized photothermal vaccine formulation for cancer immunotherapy","volume":"13","author":"Ye","year":"2019","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib234","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16080-y","article-title":"GM-CSF derived from the inflammatory microenvironment potentially enhanced PD-L1 expression on tumor-associated macrophages in human breast cancer","volume":"12","author":"Yonemitsu","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104804_bib235","article-title":"Induction of monocyte chemoattractant proteins in macrophages via the production of Granulocyte\/Macrophage Colony-Stimulating factor by breast cancer cells","volume":"7","author":"Yoshimura","year":"2016","journal-title":"Front Immunol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104804_bib236","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1002\/ijc.28302","article-title":"Deficiency of Kruppel-like factor KLF4 in mammary tumor cells inhibits tumor growth and pulmonary metastasis and is accompanied by compromised recruitment of myeloid-derived suppressor cells","volume":"133","author":"Yu","year":"2013","journal-title":"Int J. Cancer"},{"issue":"34","key":"10.1016\/j.critrevonc.2025.104804_bib237","article-title":"PD-1 inhibitor combined with SBRT, GM-CSF, and thymosin alpha-1 in metastatic breast cancer: a case report and literature review","volume":"103","author":"Yu","year":"2024","journal-title":"Med. (Baltim.)"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104804_bib238","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00262-024-03934-9","article-title":"Hypofractionated radiotherapy combined with a PD-1 inhibitor, granulocyte macrophage-colony stimulating factor, and thymosin-\u03b11 in advanced metastatic solid tumors: a multicenter phase II clinical trial","volume":"74","author":"Yu","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2025.104804_bib239","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104200","article-title":"Interleukin-1 receptor accessory protein (IL-1RAP): a magic bullet candidate for immunotherapy of human malignancies","volume":"193","author":"Zarezadeh Mehrabadi","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2025.104804_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104576","article-title":"Advancing tumor vaccines: overcoming TME challenges, delivery strategies, and biomaterial-based vaccine for enhanced immunotherapy","volume":"205","author":"Zeng","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib241","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1038\/s41467-022-33365-y","article-title":"The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.104804_bib242","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3389\/fimmu.2020.01779","article-title":"A rosetta stone for breast cancer: prognostic value and dynamic regulation of neutrophil in tumor microenvironment","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol."},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104804_bib243","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.7150\/jca.25423","article-title":"PD-1 blockade overcomes adaptive immune resistance in treatment with Anchored-GM-CSF bladder cancer cells vaccine","volume":"9","author":"Zhang","year":"2018","journal-title":"J. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104804_bib244","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104804_bib245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12935-023-02934-6","article-title":"Local radiotherapy for murine breast cancer increases risk of metastasis by promoting the recruitment of M-MDSCs in lung","volume":"23","author":"Zhang","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104804_bib246","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/CM9.0000000000000710","article-title":"Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1\/programmed cell death protein ligand-1","volume":"133","author":"Zhao","year":"2020","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.critrevonc.2025.104804_bib247","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2021.07.010","article-title":"Breast cancer heterogeneity through the lens of single-cell analysis and spatial pathologies","volume":"82","author":"Zhao","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104804_bib248","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.cmet.2023.09.004","article-title":"Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1","volume":"35","author":"Zhao","year":"2023","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104804_bib249","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1007\/s00432-023-04574-9","article-title":"HER2\/neu-based vaccination with li-Key hybrid, GM-CSF immunoadjuvant and trastuzumab as a potent triple-negative breast cancer treatment","volume":"149","author":"Zhou","year":"2023","journal-title":"J. Cancer Res Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104804_bib250","article-title":"Breast cancer vaccines: disappointing or promising?","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol."},{"issue":"46","key":"10.1016\/j.critrevonc.2025.104804_bib251","article-title":"Prolonged survival of neutrophils induced by Tumor-Derived G-CSF\/GM-CSF promotes immunosuppression and progression in laryngeal squamous cell carcinoma","volume":"11","author":"Zhu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825001921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825001921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:09:55Z","timestamp":1758589795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825001921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":251,"alternative-id":["S1040842825001921"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104804","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual roles of GM-CSF in breast cancer: Immunomodulation and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104804"}}